Questions for Intel Apps Support to Targeting.pdf

Questions for Support to Targeting – Intelligence Automation (Intel Apps)

1. Although this demonstration has passed, is the vendor required to utilize AWS for all development in the test-fix-test model approach? Or can other services be used such as

Azure or GCP (Google Cloud Platform) for the GPU’s needed for ML models?

a. Answer: The vendor is not required to utilize AWS for all development in the test fix test. The current TSIv2 stack does not have any GPUs on them.

2. Since the development cycle is to be one that requires a rapid turnaround, as with the test-fix-test approach. What time duration will the Government POC or control group, who will be providing the application feedback, have to respond to the vendor development team? As this would have an impact on the development of the solutions final production rollout milestone.

a. Answer: The Government will immediately provide feedback during the Test Fix

Test events. As soon as any issues arise during TFT, we will notify the vendor .

3. Since the cost of GPU’s varies, and is in a state of flux, the cost will likely change within the 180 day time period, will the vendor be able to adjust this cost factor during the IDIQ period? As it is unknown, and will also have an impact on the amount of time and data that is required for training epochs\hyperparameters for the ML models.\

a. Answer: the current TSIv2 stack does not have any GPUs on them.

4. The statement of work and Pricing file do not match up, which of these two is accurate? Will an amendment be provided if necessary?

a. Answer: Refer to SV-1

5. The PRD (Attachment 002) calls out SV-1 and SV-6 material as a reference point and indicated it was provided as part of the package for the RFP. However, it is not included in the material package. Can this please be provided for our reference and understanding?

a. Answer: Refer to SV-1

6. In the demo plan, there is a mention of "Publish to CPCE", but there is no step listed in

Annex A for the demo that specifically call for this. Will publishing to CPCE be part of the demo? What type of publishing is expected? DDS advertisement for Graphics, or something else?

a. Answer: There is no publishing to CPCE.

7. For CLIN 16 - Licensing, how many times will this CLIN be executed? What will it be executed for? Would this CLIN likely be executed just once, likely in just the first year?

a. Answer: CLIN 0016 is for Exercise Support, which will be on an "As Needed" basis.

b. There is no guaranteed quantity each year, however 2 events per year are anticipated.

8. The statement of work indicated JITC testing would occur as a SoW item. However, the

TEP does not have JITC testing listed. Which item is correct, the SoW, or TEP? Is a new TEP needed that includes JITC testing in the affordability tab?

a. Answer: There will be no JITC Testing. The TEP is correct. There are no joint requirements for ISTT.

9. In document W56KGY22R0005 there are multiple references to the “All Source II

Software Solution” instead of Intelligence Support to Targeting.

a. Answer: Intelligence Support to Targeting is the correct title of this requirement.

10. The statement of work and Pricing file do not match up, which of these two is accurate? Will an amendment be provided if necessary?

a. Answer: Yes.

11. The PRD (Attachment 002) calls out SV-1 and SV-6 material as a reference point and indicated it was provided as part of the package for the RFP. However, it is not included in the material package. Can this please be provided for our reference and understanding?

a. Answer: Please refer to the product library (TGT App Engineering Diagrams –

PowerPoint)

12. I’ve not had much luck getting a response on the NDA request from the Aspen POC listed on the RFP. Is there by chance another POC for Aspen that we should be sending the NDA requests to?

a. Answer: Theresa Stewart